{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:27:26Z","timestamp":1789522046074,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,4,20]],"date-time":"2013-04-20T00:00:00Z","timestamp":1366416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00066-013-0321-6","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T07:52:38Z","timestamp":1366271558000},"page":"467-475","source":"Crossref","is-referenced-by-count":11,"title":["Interstitial hyperthermia of the prostate in combination with brachytherapy","Interstitielle Hyperthermie der Prostata in Kombination mit Brachytherapie"],"prefix":"10.1007","volume":"189","author":[{"given":"A.M.","family":"Kukie\u0142ka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hetna\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Brandys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Walasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"D\u0105browski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pluta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Nahajowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kudzia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,20]]},"reference":[{"key":"321_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1098-2388(199910\/11)17:3<213::AID-SSU11>3.0.CO;2-P","volume":"17","author":"Krumholtz","year":"1999","unstructured":"Krumholtz JS, Andriole GL (1999) The surgery of prostate cancer: an update of contemporary radical prostatectomy and brachytherapy series. Semin Surg Oncol 17(3):213\u2013218","journal-title":"Semin Surg Oncol"},{"key":"321_CR2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"D","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280(11):969\u2013974","journal-title":"JAMA"},{"key":"321_CR3","doi-asserted-by":"crossref","unstructured":"Pisansky TM, Thames HD, Levy LB et al (2004) Clinical outcomes and prognostic factors in 4,839 patients treated with external radiotherapy for stage T1-T2 prostate cancer [abstract 63]. Proceedings of the annual ASTRO meeting, Int J Radiat Oncol Biol Phys 60:S167","DOI":"10.1016\/j.ijrobp.2004.06.089"},{"key":"321_CR4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0360-3016(99)00089-9","volume":"44","author":"Zagars","year":"1999","unstructured":"Zagars GK, Pollack A, Smith LG (1999) Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX\/N0, M0) adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 44(4):809\u2013819","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR5","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jama.281.17.1598","volume":"281","author":"Shipley","year":"1999","unstructured":"Shipley WU, Thames HD, Sandler HM et al (1999) Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 281(17):1598\u20131604","journal-title":"JAMA"},{"key":"321_CR6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1470-2045(05)70348-X","volume":"6","author":"Denham","year":"2005","unstructured":"Denham JW, Steigler A, Lamb DS et al (2005) Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol 6(11):841\u2013850","journal-title":"Lancet Oncol"},{"key":"321_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","volume":"337","author":"Bolla","year":"1997","unstructured":"Bolla M, Gonzalez D, Warde P et al (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337(5):295\u2013300","journal-title":"N Engl J Med"},{"key":"321_CR8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.292.7.821","volume":"292","author":"D","year":"2004","unstructured":"D\u2019Amico AV, Manola J, Loffredo M et al (2004) 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA 292(7):821\u2013827","journal-title":"JAMA"},{"key":"321_CR9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0360-3016(98)00091-1","volume":"41","author":"Zelefsky","year":"1998","unstructured":"Zelefsky MJ, Leibel SA, Gaudin PB et al (1998) Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41(3):491\u2013500","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2008.10.091","volume":"74","author":"Viani","year":"2009","unstructured":"Viani GA, Stefano EJ, Afonso SL (2009) Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 74(5):1405\u20131418","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"Roach","year":"2006","unstructured":"Roach M IIIrd, Hanks G, Thames H Jr et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therpy in men with clinically localized prostate cancer. Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65:965\u2013974","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2006.10.012","volume":"67","author":"Lee","year":"2007","unstructured":"Lee B, Shinohara K, Weinberg V et al (2007) Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 67(4):1106\u20131112","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cncr.22941","volume":"110","author":"Nguyen","year":"2007","unstructured":"Nguyen PL, D\u2019Amico AV, Lee AK, Suh WW (2007) Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 110(7):1417\u20131428","journal-title":"Cancer"},{"key":"321_CR14","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J et al (2012) Guidelines on prostate cancer. European association of urology. http:\/\/www.uroweb.org\/gls\/pdf\/08%20Prostate%20Cancer_LR%20March%2013th%202012.pdf"},{"key":"321_CR15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0360-3016(95)02017-9","volume":"34","author":"Ryu","year":"1996","unstructured":"Ryu S, Brown SL, Kim SH et al (1996) Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys 34(1):133\u2013138","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/095530096144824","volume":"70","author":"Peschke","year":"1996","unstructured":"Peschke P, Hahn EW, Wolber G et al (1996) Interstitial radiation and hyperthermia in the Dunning R3327 prostate tumour model: therapeutic efficacy depends on radiation dose-rate, sequence and frequency of heating. Int J Radiat Biol 70(5):609\u2013616","journal-title":"Int J Radiat Biol"},{"key":"321_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/02656730701553260","volume":"23","author":"Maluta","year":"2007","unstructured":"Maluta S, Dall\u2019Oglio S, Romano M et al (2007) Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study. Int J Hyperthermia 23(5):451\u2013456","journal-title":"Int J Hyperthermia"},{"key":"321_CR18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1464-410X.2004.04551.x","volume":"93","author":"Van","year":"2004","unstructured":"Van Vulpen M, De Leeuw AA, Raaymakers BW et al (2004) Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results. BJU Int 93(1):36\u201341","journal-title":"BJU Int"},{"key":"321_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00066-005-1296-8","volume":"181","author":"Tilly","year":"2005","unstructured":"Tilly W, Gellermann J, Graf R et al (2005) Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 181(1):35\u201341","journal-title":"Strahlenther Onkol"},{"key":"321_CR20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/02656730903091986","volume":"25","author":"Overgaard","year":"2009","unstructured":"Overgaard J, Gonzalez Gonzalez D, Hulshof MC et al (2009) Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996. Int J Hyperthermia 25(5):323\u2013334","journal-title":"Int J Hyperthermia"},{"key":"321_CR21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0360-3016(96)00154-X","volume":"35","author":"Vernon","year":"1996","unstructured":"Vernon CC, Hand JW, Field SB et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 35(4):731\u2013744","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(00)02059-6","volume":"355","author":"Zee","year":"2000","unstructured":"Zee J van der, Gonz\u00e1lez Gonz\u00e1lez D, Rhoon GC van et al (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355(9210):1119\u20131125","journal-title":"Lancet"},{"key":"321_CR23","first-page":"143","volume":"23","author":"Baronzio","year":"2009","unstructured":"Baronzio G, Gramaglia A, Fiorentini G (2009) Review. Current role and future perspectives of hyperthermia for prostate cancer treatment. In Vivo 23(1):143\u2013146","journal-title":"In Vivo"},{"key":"321_CR24","unstructured":"NCCN Clinical Practice Guidelines in Oncology (2012) Prostate cancer, version 1.2013. NCCN; 2012. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf"},{"key":"321_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2005.06.009","volume":"76","author":"Bentzen","year":"2005","unstructured":"Bentzen S, Ritter MA (2005) The \u03b1\/\u03b2 ratio for prostate cancer: what is it, really? Radiother Oncol 76(1):1\u20133","journal-title":"Radiother Oncol"},{"key":"321_CR26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.radonc.2011.07.017","volume":"101","author":"Valdagni","year":"2011","unstructured":"Valdagni R, Nahum AE, Magnani T et al (2011) Long-term biochemical control of prostate cancer after standard or hyper-fractionation: evidence for different outcomes between low-intermediate and high risk patients. Radiother Oncol 101(3):454\u2013459","journal-title":"Radiother Oncol"},{"key":"321_CR27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ijrobp.2004.07.723","volume":"61","author":"Cheung","year":"2005","unstructured":"Cheung R, Tucker SL, Lee AK et al (2005) Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61(4):993\u20131002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2004.09.004","volume":"74","author":"Kov\u00e1cs","year":"2005","unstructured":"Kov\u00e1cs G, P\u00f6tter R, Loch T et al (2005) GEC\/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol 74(2):137\u2013148","journal-title":"Radiother Oncol"},{"key":"321_CR29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0360-3016(94)90011-6","volume":"30","author":"Diaz","year":"1994","unstructured":"Diaz A, Roach M IIIrd, Marquez C et al (1994) Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 30(2):323\u2013329","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR30","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.urology.2007.03.042","volume":"69","author":"Makarov","year":"2007","unstructured":"Makarov DV, Trock BJ, Humphreys EB et al (2007) Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 69(6):1095\u20131101","journal-title":"Urology"},{"key":"321_CR31","unstructured":"http:\/\/www.rtog.org\/CoreLab\/ContouringAtlases\/ProstatePelvicLymphNodes.aspx. Accessed 31 Dec 2012"},{"key":"321_CR32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/0265673031000063855","volume":"19","author":"Van","year":"2003","unstructured":"Van Vulpen M, De Leeuw JR, Van Gellekom MP et al (2003) A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia. Int J Hyperthermia 19(4):402\u2013413","journal-title":"Int J Hyperthermia"},{"key":"321_CR33","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.brachy.2010.02.117","volume":"9","author":"Mohammed","year":"2010","unstructured":"Mohammed N, Ghilezan MI, Kestin L et al (2010) High dose rate re-irradiation with continuos hyperthermia for recurrent prostate cancer. Brachytherapy 9:S72","journal-title":"Brachytherapy"},{"key":"321_CR34","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.brachy.2007.02.065","volume":"6","author":"Williams","year":"2007","unstructured":"Williams V, Puthawala A, Phan TP et al (2007) Interstitial hyperthermia during HDR brachytherapy monotherapy for treatment of early stage prostate cancer with benign prostate hyperplasia. Brachytherapy 6:S86","journal-title":"Brachytherapy"},{"key":"321_CR35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0360-3016(94)90153-8","volume":"28","author":"Prionas","year":"1994","unstructured":"Prionas SD, Kapp DS, Goffinet DR et al (1994) Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 28(1):151\u2013162","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","volume":"91","author":"Sullivan","year":"2009","unstructured":"Sullivan L, Williams SG, Tai KH et al (2009) Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol 91:232\u2013236","journal-title":"Radiother Oncol"},{"key":"321_CR37","unstructured":"Khor R, Duchesne G, Tai KH et al (n d) Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer. Int J Radiat Oncol Biol Phys (In Press Corrected Proof)"},{"key":"321_CR38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.radonc.2012.07.003","volume":"104","author":"Lettmaier","year":"2012","unstructured":"Lettmaier S, Lotter M, Kreppner S et al (2012) Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer. Radiother Oncol 104(2):181\u2013186. doi:10.1016\/j.radonc.2012.07.003. (Epub 2012 Jul 30)","journal-title":"Radiother Oncol"},{"key":"321_CR39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/0265673031000096327","volume":"19","author":"Van","year":"2003","unstructured":"Van Vulpen M, De Leeuw AA, Van De Kamer JB et al (2003) Comparison of intra-luminal versus intra-tumoural temperature measurements in patients with locally advanced prostate cancer treated with the coaxial TEM system: report of a feasibility study. Int J Hyperthermia 19(5):481\u2013497","journal-title":"Int J Hyperthermia"},{"key":"321_CR40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1464-410X.2004.04551.x","volume":"93","author":"Van","year":"2004","unstructured":"Van Vulpen M, De Leeuw AA, Raaymakers BW et al (2004) Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results. BJU Int 93(1):36\u201341","journal-title":"BJU Int"},{"key":"321_CR41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/02656730500331967","volume":"21","author":"Hurwitz","year":"2005","unstructured":"Hurwitz MD, Kaplan ID, Hansen JL et al (2005) Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile. Int J Hyperthermia 21(7):649\u2013656","journal-title":"Int J Hyperthermia"},{"key":"321_CR42","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/cncr.25619","volume":"117","author":"Hurwitz","year":"2011","unstructured":"Hurwitz MD, Hansen JL, Prokopios-Davos S et al (2011) Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94\u2013153. Cancer 117(3):510\u2013516. doi:10.1002\/cncr.25619","journal-title":"Cancer"},{"key":"321_CR43","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1259\/bjr.74.884.740745","volume":"74","author":"Kalapurakal","year":"2001","unstructured":"Kalapurakal JA, Mittal BB, Sathiaseelan V (2001) Re-irradiation and external hyperthermia in locally advanced, radiation recurrent, hormone refractory prostate cancer: a preliminary report. Br J Radiol 74(884):745\u2013751","journal-title":"Br J Radiol"},{"key":"321_CR44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0360-3016(03)00625-4","volume":"57","author":"Kalapurakal","year":"2003","unstructured":"Kalapurakal JA, Pierce M, Chen A, Sathiaseelan V (2003) Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer: a preliminary report. Int J Radiat Oncol Biol Phys 57(3):654\u2013664","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"321_CR45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","volume":"11","author":"Yamada","year":"2012","unstructured":"Yamada Y, Rogers L, Demanes DJ et al (2012) American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy 11(1):20\u201332","journal-title":"Brachytherapy"},{"key":"321_CR46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00066-011-1145-x","volume":"187","author":"Bruggmoser","year":"2011","unstructured":"Bruggmoser G, Bauchowitz S, Canters R et al (2011) Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 187(10):605\u2013610","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-013-0321-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-013-0321-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-013-0321-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T15:56:57Z","timestamp":1562947017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-013-0321-6"}},"subtitle":["An evaluation of feasibility and early tolerance","Eine Bewertung von Realisierbarkeit und fr\u00fcher Toleranz"],"short-title":[],"issued":{"date-parts":[[2013,4,20]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1007\/s00066-013-0321-6","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,20]]}}}